A recent article in The Conversation U.S. highlights cutting-edge research from the Mangalam Lab in the Department of Pathology at the University of Iowa, based on their newly published study in PNAS. The study uncovers a key link between gut microbiota and multiple sclerosis (MS), identifying a specific bacterial ratio that may act as a biomarker for the disease and help predict its severity.